Ledger.Open graph →
SEC Form D · filed October 31, 2023

Harpoon Therapeutics, Inc

Offering
$100.2M
Sold
$100.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Luke N. Walker · South San Francisco, CAExecScott Myers · South San Francisco, CADirectorJoseph Bailes · South San Francisco, CADirectorMark Chin · South San Francisco, CADirectorJulie Eastland · South San Francisco, CAExec · DirectorAndrew Robbins · South San Francisco, CADirectorLauren P. Silvernail · South San Francisco, CADirectorJonathan Drachman · South San Francisco, CADirectorRonald Hunt · South San Francisco, CADirectorArthur Yakubovsky · George Town, Grand Cayman, Cayman IslandsDirectorSean S. Warren · ONTARIO, CADirectorPorter B. Openshaw · Salt Lake City, UTDirectorCarine S. Clark · ONTARIO, CAExec · DirectorEdward S. Lee · ONTARIO, CADirectorMichael S. Pope · ONTARIO, CADirectorDesheng Wang · ONTARIO, CADirectorIrving S. Kau · ONTARIO, CAExecBrian F. Semel · Northbrook, ILDirectorJason Kao · New York, NYDirectorJulie Mcdonald · New York, NYDirectorCatherine Valeri · New York, NYDirectorJustin Macneil · New York, NYDirectorAlberto Autmezguine · New York, NYDirectorAriel S. Trybuch · carlsbad, CAExecArjun S. Sethi · Campbell, CAExec · DirectorJay Zaveri · Campbell, CADirectorTim Manion · Omaha, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗